Burning Rock Biotech (BNR) Accumulated Depreciation & Amortization (2020 - 2024)
Historic Accumulated Depreciation & Amortization for Burning Rock Biotech (BNR) over the last 5 years, with Q4 2024 value amounting to $7.2 million.
- Burning Rock Biotech's Accumulated Depreciation & Amortization fell 6194.05% to $7.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $7.2 million, marking a year-over-year decrease of 6194.05%. This contributed to the annual value of $7.2 million for FY2024, which is 6194.05% down from last year.
- Latest data reveals that Burning Rock Biotech reported Accumulated Depreciation & Amortization of $7.2 million as of Q4 2024, which was down 6194.05% from $18.8 million recorded in Q4 2023.
- Burning Rock Biotech's 5-year Accumulated Depreciation & Amortization high stood at $18.8 million for Q4 2023, and its period low was $5.1 million during Q4 2020.
- Its 5-year average for Accumulated Depreciation & Amortization is $10.9 million, with a median of $8.2 million in 2021.
- In the last 5 years, Burning Rock Biotech's Accumulated Depreciation & Amortization surged by 14002.13% in 2022 and then plummeted by 6194.05% in 2024.
- Over the past 5 years, Burning Rock Biotech's Accumulated Depreciation & Amortization (Quarter) stood at $5.1 million in 2020, then skyrocketed by 46.84% to $7.5 million in 2021, then surged by 140.02% to $18.0 million in 2022, then rose by 4.43% to $18.8 million in 2023, then crashed by 61.94% to $7.2 million in 2024.
- Its Accumulated Depreciation & Amortization was $7.2 million in Q4 2024, compared to $18.8 million in Q4 2023 and $18.0 million in Q4 2022.